Similar articles

Abstract: Transcatheter valve implantation or repair has been a very promising approach for the treatment of valvular heart diseases since transcatheter aortic valve implantation (TAVI) was successfully performed in 2002. Great achievements have been made in this field (especially TAVI and transcatheter mitral valve repair—mitraClip system) in recent years. Evidence from clinical trials or registry studies has proved that transcatheter valve treatment for valvular heart diseases is safe and effective in surgical high-risk or inoperable patients. As the evidence accumulates, transcatheter valve treatment might be an alterative surgery for younger patients with surgically low or intermediate risk valvular heart diseases in the near future. In this paper, the updates on transcatheter valve treatment are reviewed.

[1]Andersen, H.R., Knudsen, L.L., Hasenkam, J.M., 1992. Transluminal implantation of artificial heart valves. Description of a new expandable aortic valve and initial results with implantation by catheter technique in closed chest pigs. Eur. Heart J., 13(5):704-708.

[2]Auricchio, A., Schillinger, W., Meyer, S., Maisano, F., Hoffmann, R., Ussia, G.P., Pedrazzini, G.B., van der Heyden, J., Fratini, S., Klersy, C., et al., 2011. Correction of mitral regurgitation in nonresponders to cardiac resynchronization therapy by MitraClip improves symptoms and promotes reverse remodeling. J. Am. Coll. Cardiol., 58(21):2183-2189.

[3]Baldus, S., Schillinger, W., Franzen, O., Bekeredjian, R., Sievert, H., Schofer, J., Kuck, K.H., Konorza, T., Möllmann, H., Hehrlein, C., et al., 2012. MitraClip therapy in daily clinical practice: initial results from the German transcatheter mitral valve interventions (TRAMI) registry. Eur. J. Heart Fail., 14(9):1050-1055.

[4]Beckmann, A., Hamm, C., Figulla, H.R., Cremer, J., Kuck, K.H., Lange, R., Zahn, R., Sack, S., Schuler, G.C., Walther, T., et al., 2012. The German aortic valve registry (GARY): a nationwide registry for patients undergoing invasive therapy for severe aortic valve stenosis. Thorac. Cardiovasc. Surg., 60(5):319-325.

[5]Bonhoeffer, P., Boudjemline, Y., Saliba, Z., Merckx, J., Aggoun, Y., Bonnet, D., Acar, P., Le Bidois, J., Sidi, D., Kachaner, J., 2000. Percutaneous replacement of pulmonary valve in a right-ventricle to pulmonary-artery prosthetic conduit with valve dysfunction. Lancet, 356(9239):1403-1405.

[6]Bosmans, J.M., Kefer, J., de Bruyne, B., Herijgers, P., Dubois, C., Legrand, V., Verheye, S., Rodrigus, I., Belgian TAVI Registry Participants, 2011. Procedural, 30-day and one year outcome following CoreValve or Edwards transcatheter aortic valve implantation: results of the Belgian national registry. Interact. Cardiovasc. Thorac. Surg., 12(5):762-767.

[7]Cheung, A., Webb, J.G., Wong, D.R., Ye, J., Masson, J.B., Carere, R.G., Lichtenstein, S.V., 2009. Transapical transcatheter mitral valve-in-valve implantation in a human. Ann. Thorac. Surg., 87(3):e18-e20.

[8]Cribier, A., Eltchaninoff, H., Bash, A., Borenstein, N., Tron, C., Bauer, F., Derumeaux, G., Anselme, F., Laborde, F., Leon, M.B., 2002. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation, 106(24):3006-3008.

[9]Dahle, G., Fiane, A.E., Rein, K.A., 2012. Transapical 29 mm Edwards SAPIEN-XT aortic valve in a 34-mm mitral annuloplasty ring. Innov. Technol. Techn. Cardiothor. Vascular Surg., 7(4):290-294.

[10]Descoutures, F., Himbert, D., Maisano, F., Casselman, F., de Weger, A., Bodea, O., van der Kley, F., Colombo, A., Giannini, C., Rein, K.A., et al., 2013. Transcatheter valve-in-ring implantation after failure of surgical mitral repair. Eur. J. Cardiothorac. Surg., 44(1):e8-e15.

[11]Dumonteil, N., Marcheix, B., Lairez, O., Laborde, J.C., 2013. Transcatheter aortic valve implantation for severe, non-calcified aortic regurgitation and narrow aortic root: description from a case report of a new approach to potentially avoid coronary artery obstruction. Catheter. Cardiovasc. Interv., 82(2):E124-E127.

[12]Dvir, D., Webb, J., Brecker, S., Bleiziffer, S., Hildick-Smith, D., Colombo, A., Descoutures, F., Hengstenberg, C., Moat, N.E., Bekeredjian, R., et al., 2012. Transcatheter aortic valve replacement for degenerative bioprosthetic surgical valves: results from the global valve-in-valve registry. Circulation, 126(19):2335-2344.

[13]Eicken, A., Ewert, P., Hager, A., Peters, B., Fratz, S., Kuehne, T., Busch, R., Hess, J., Berger, F., 2011. Percutaneous pulmonary valve implantation: two-centre experience with more than 100 patients. Eur. Heart J., 32(10):1260-1265.

[14]Feldman, T., Kar, S., Rinaldi, M., Fail, P., Hermiller, J., Smalling, R., Whitlow, P.L., Gray, W., Low, R., Herrmann, H.C., et al., 2009. Percutaneous mitral repair with the MitraClip system: safety and midterm durability in the initial EVEREST (Endovascular Valve Edge-to-Edge REpair Study) cohort. J. Am. Coll. Cardiol., 54(8):686-694.

[15]Feltes, T.F., Bacha, E., Beekman, R.H.3rd, Cheatham, J.P., Feinstein, J.A., Gomes, A.S., Hijazi, Z.M., Ing, F.F., de Moor, M., Morrow, W.R., et al., 2011. Indications for cardiac catheterization and intervention in pediatric cardiac disease: a scientific statement from the American Heart Association. Circulation, 123(22):2607-2652.

[16]Gilard, M., Eltchaninoff, H., Iung, B., Donzeau-Gouge, P., Chevreul, K., Fajadet, J., Leprince, P., Leguerrier, A., Lievre, M., Prat, A., et al., 2012. Registry of transcatheter aortic-valve implantation in high-risk patients. N. Engl. J. Med., 366(18):1705-1715.

[17]Gillespie, M.J., Rome, J.J., Levi, D.S., Williams, R.J., Rhodes, J.F., Cheatham, J.P., Hellenbrand, W.E., Jones, T.K., Vincent, J.A., Zahn, E.M., et al., 2012. Melody valve implant within failed bioprosthetic valves in the pulmonary position: a multicenter experience. Circ. Cardiovasc., 5(6):862-870.

[18]Grasso, C., Capodanno, D., Scandura, S., Cannata, S., Immè, S., Mangiafico, S., Pistritto, A., Ministeri, M., Barbanti, M., Caggegi, A., et al., 2013. One- and twelve-month safety and efficacy outcomes of patients undergoing edge-to-edge percutaneous mitral valve repair (from the GRASP registry). Am. J. Cardiol., 111(10):1482-1487.

[19]Greif, M., Lange, P., Mair, H., Becker, C., Schmitz, C., Steinbeck, G., Kupatt, C., 2012. Transcatheter Edwards Sapien XT valve in valve implantation in degenerated aortic bioprostheses via transfemoral access. Clin. Res. Cardiol., 101(12):993-1001.

[20]Himbert, D., Pontnau, F., Messika-Zeitoun, D., Descoutures, F., Détaint, D., Cueff, C., Sordi, M., Laissy, J.P., Alkhoder, S., Brochet, E., et al., 2012. Feasibility and outcomes of transcatheter aortic valve implantation in high-risk patients with stenotic bicuspid aortic valves. Am. J. Cardiol., 110(6):877-883.

[21]Holmes, D.R., Mack, M.J., Kaul, S., Agnihotri, A., Alexander, K.P., Bailey, S.R., Calhoon, J.H., Carabello, B.A., Desai, M.Y., Edwards, F.H., et al., 2012. 2012 ACCF/AATS/ SCAI/STS expert consensus document on transcatheter aortic valve replacement. J. Am. Coll. Cardiol., 59(13):1200-1254.

[22]Khambadkone, S., Coats, L., Taylor, A., Boudjemline, Y., Derrick, G., Tsang, V., Cooper, J., Muthurangu, V., Hegde, S.R., Razavi, R.S., et al., 2005. Percutaneous pulmonary valve implantation in humans: results in 59 consecutive patients. Circulation, 112(8):1189-1197.

[23]Kodali, S.K., Williams, M.R., Smith, C.R., Svensson, L.G., Webb, J.G., Makkar, R.R., Fontana, G.P., Dewey, T.M., Thourani, V.H., Pichard, A.D., et al., 2012. Two-year outcomes after transcatheter or surgical aortic-valve replacement. N. Engl. J. Med., 366(18):1686-1695.

[24]Lange, R., Bleiziffer, S., Mazzitelli, D., Elhmidi, Y., Opitz, A., Krane, M., Deutsch, M.A., Ruge, H., Brockmann, G., Voss, B., et al., 2012. Improvements in transcatheter aortic valve implantation outcomes in lower surgical risk patients: a glimpse into the future. J. Am. Coll. Cardiol., 59(3):280-287.

[25]Maisano, F., Franzen, O., Baldus, S., Schäfer, U., Hausleiter, J., Butter, C., Ussia, G.P., Sievert, H., Richardt, G., Widder, J.D., et al., 2013. Percutaneous mitral valve interventions in the real world: early and one year results from the ACCESS-EU, a prospective, multicenter, non-randomized post-approval study of the MitraClip® therapy in Europe. J. Am. Coll. Cardiol., in press.

[26]Makkar, R.R., Fontana, G.P., Jilaihawi, H., Kapadia, S., Pichard, A.D., Douglas, P.S., Thourani, V.H., Babaliaros, V.C., Webb, J.G., Herrmann, H.C., et al., 2012. Transcatheter aortic-valve replacement for inoperable severe aortic stenosis. N. Engl. J. Med., 366(18):1696-1704.

[27]Mauri, L., Foster, E., Glower, D.D., Apruzzese, P., Massaro, J.M., Herrmann, H.C., Hermiller, J., Gray, W., Wang, A., Pedersen, W.R., et al., 2013. 4-year results of a randomized controlled trial of percutaneous repair versus surgery for mitral regurgitation. J. Am. Coll. Cardiol., 62(4):317-328.

[28]Mazzitelli, D., Bleiziffer, S., Noebauer, C., Ruge, H., Mayr, P., Opitz, A., Tassani-Prell, P., Schreiber, C., Piazza, N., Lange, R., 2013. Transatrial antegrade approach for double mitral and tricuspid “valve-in-ring” implantation. Ann. Thorac. Surg., 95(1):e25-e27.

[29]McElhinney, D.B., Hellenbrand, W.E., Zahn, E.M., Jones, T.K., Cheatham, J.P., Lock, J.E., Vincent, J.A., 2010. Short- and medium-term outcomes after transcatheter pulmonary valve placement in the expanded multicenter US melody valve trial. Circulation, 122(5):507-516.

[30]Nombela-Franco, L., Urena, M., Ribeiro, H.B., Rodés-Cabau, J., 2013. Advances in percutaneous treatment of mitral regurgitation. Rev. Esp. Cardiol., 66(7):566-582 (in Spanish).

[31]Piazza, N., Schultz, C., de Jaegere, P.P., Serruys, P.W., 2009. Implantation of two self-expanding aortic bioprosthetic valves during the same procedure-Insights into valve-in-valve implantation (“Russian doll concept”). Catheter. Cardiovasc. Interv., 73(4):530-539.

[32]Rudolph, V., Knap, M., Franzen, O., Schlüter, M., de Vries, T., Conradi, L., Schirmer, J., Treede, H., Wegscheider, K., Costard-Jäckle, A., et al., 2011. Echocardiographic and clinical outcomes of MitraClip therapy in patients not amenable to surgery. J. Am. Coll. Cardiol., 58(21):2190-2195.

[33]Smith, C.R., Leon, M.B., Mack, M.J., Miller, D.C., Moses, J.W., Svensson, L.G., Tuzcu, E.M., Webb, J.G., Fontana, G.P., Makkar, R.R., et al., 2011. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N. Engl. J. Med., 364(23):2187-2198.

[34]Stabile, E., Sorropago, G., Cota, L., Cioppa, A., Agrusta, M., Lucchetti, V., Rubino, P., 2010. Management of percutaneous aortic valve malposition with a transapical “valve-in-valve” technique. Ann. Thorac. Surg., 89(4):e19-e21.

[35]Stortecky, S., Buellesfeld, L., Wenaweser, P., Windecker, S., 2012. Transcatheter aortic valve implantation: prevention and management of complications. Heart, 98(S4):iv52-iv64.

[36]Sürder, D., Pedrazzini, G., Gaemperli, O., Biaggi, P., Felix, C., Rufibach, K., Maur, C.A., Jeger, R., Buser, P., Kaufmann, B.A., et al., 2013. Predictors for efficacy of percutaneous mitral valve repair using the MitraClip system: the results of the MitraSwiss registry. Heart, 99:1034-1040.

[37]Thomas, M., Schymik, G., Walther, T., Himbert, D., Lefèvre, T., Treede, H., Eggebrecht, H., Rubino, P., Colombo, A., Lange, R., et al., 2011. One-year outcomes of cohort 1 in the Edwards SAPIEN Aortic Bioprosthesis European Outcome (SOURCE) registry: the European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve. Circulation, 124(4):425-433.

[38]Vahanian, A., Alfieri, O., Andreotti, F., Antunes, M.J., Barón-Esquivias, G., Baumgartner, H., Borger, M.A., Carrel, T.P., de Bonis, M., Evangelista, A., et al., 2012. Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC); European Association for Cardio-Thoracic Surgery (EACTS), Guidelines on the Management of Valvular Heart Disease (Version 2012). Eur. Heart. J., 33(19):2451-2496.

[39]Webb, J.G., Wood, D.A., Ye, J., Gurvitch, R., Masson, J.B., Rodés-Cabau, J., Osten, M., Horlick, E., Wendler, O., Dumont, E., et al., 2010. Transcatheter valve-in-valve implantation for failed bioprosthetic heart valves. Circulation, 121(16):1848-1857.

[40]Wenaweser, P., Buellesfeld, L., Gerckens, U., Grube, E., 2007. Percutaneous aortic valve replacement for severe aortic regurgitation in degenerated bioprosthesis: the first valve in valve procedure using the CoreValve revalving system. Catheter. Cardiovasc. Interv., 70(5):760-764.

[41]Whitlow, P.L., Feldman, T., Pedersen, W.R., Lim, D.S., Kipperman, R., Smalling, R., Bajwa, T., Herrmann, H.C., Lasala, J., Maddux, J.T., et al., 2012. Acute and 12-month results with catheter-based mitral valve leaflet repair: the EVEREST II (endovascular valve edge-to-edge repair) high risk study. J. Am. Coll. Cardiol., 59(2):130-139.

[42]Zahn, E.M., Hellenbrand, W.E., Lock, J.E., McElhinney, D.B., 2009. Implantation of the melody transcatheter pulmonary valve in patients with a dysfunctional right ventricular outflow tract conduit: early results from the U.S. clinical trial. J. Am. Coll. Cardiol., 54(18):1722-1729.